Precision Point Staffing

Great opportuntiy!

🌟🎉 Incredible Milestone Alert! 🎉🌟 We did it! We are happy to share we officially hit 3,000 amazing followers on LinkedIn! 🔬 We are beyond grateful to each and every one of you who has joined us on our page. 1,000 followers was a lot for us... but 3,000 has us over the 🌖! At Precision Point, we are trying to build a vibrant network where information is shared, and relationships are formed - so we thank you for wanting to be apart of what we are trying to build!

Attention CTA/Senior CTAs!

📢 We are hiring 📢

Hello There! #balanceoftheforce #starwars In a galaxy (not so) far, far away, within the realm of #immunology , #tcells play a crucial role similar to the force-sensitive Jedi/Sith/Rebels in Star Wars. These remarkable defenders, much like Jedi, come in two main types - the helper T cells and the killer T cells. Think of the helper T cells like Jedi such as Obi-Wan Kenobi/Anakin Skywalker, balancing the force of your immune system. They receive signals, from other immune cells and present them to the immune system council, known as the immune system command center. These inform the immune system in recognizing friend from foe, just as Jedi Masters discern the light side from the evils in the galaxy. Think of killer #tcells, like the Rebel Alliance in Star Wars - such as Han Solo/Leia Organa. They are fighters within the immune system. When activated, they transform into a powerful alliance equipped with their blasters representing cytotoxic molecules. These T cells seek out and eliminate the empire...or infected cells. The helper and killer #tcells make up the balance in your body to maintain the justice and protect the body from harm.

We are thrilled to share great news! Merck is set to acquire Harpoon Therapeutics, marking a pivotal step in further diversifying their #TCell Immunology focused pipeline for #oncology. With Merck's strong financial resources and Harpoon's cutting edge technology, we believe the sky is the limit for the future of cancer treatment! https://lnkd.in/epUJKEat

🔦 Company Spotlight 🔦 We are excited to share with you a groundbreaking organization at the forefront scientific innovation that is helping shape our environment - Colossal Biosciences. 🔬 Revolutionizing De-Extinction: Colossal Biosciences is at the forefront of scientific innovation, leveraging cutting-edge biotechnology to bring back extinct species and bolster the populations of endangered ones. Their work has the potential to reshape the future of conservation. 🌱 A Sustainable Future: Colossal Biosciences doesn't just stop at de-extinction; they are also committed to creating sustainable ecosystems that allow these resurrected creatures to thrive. It's about harmoniously integrating the past and the present for a better future. 💡 Inspiring Change: Beyond their groundbreaking technology, this organization inspires us all to take a closer look at how we can contribute to preserving our environment. They remind us that we can be the change we wish to see in the world. #Conservation #Innovation #DeExtinction #Biodiversity #Sustainability #Colossal #ProtectOurPlanet

🚀 Exciting News Alert! 🎉 We are thrilled to share that a number of companies have just secured a game-changing rounds of funding that's propelling them to new heights! We've carefully handpicked our top 3 most exhilarating contenders that have us buzzing with excitement! 🌟📈 🔬 Foundery Innovations, Inc. - Get ready to be amazed by this trailblazing San Francisco-based Biotech powerhouse. Their mission? Unleashing transformative Immunotherapies that tackle Cancer, Inflammation, Autoimmunity, and Infections head-on. And guess what? They've just locked in an impressive $29 Million to fuel their groundbreaking endeavors! 🧠 Rapport Therapeutics - Brace yourself for a revolutionary journey into the world of neurological disorders. With dual bases in Boston and San Diego, this Biotech maverick emerged from stealth mode in March, and guess what they brought along? A staggering $150 Million in Series B funding, turning heads and igniting sparks of innovation! 🔬 Cellares - South SF's dynamic IDMO is on a mission to redefine cell therapy manufacturing, and oh boy, are they succeeding! The excitement? Just reached a whole new level with a monumental $255 Million in Series C funding led by none other than Koch Disruptive Technologies 🚀 We're flipping the script and asking you: which of these game-changers has you doing the happy dance? 🕺💃 Or perhaps you've got a hidden gem up your sleeve? Share your thoughts below and let's keep the excitement going! 💬👇 #biotech #funding #immunology #immunotherapy #neurology #celltherapy